APA-viite

Pao, W., Miller, V. A., Politi, K. A., Riely, G. J., Somwar, R., Zakowski, M. F., . . . Varmus, H. (2005). Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain. Public Library of Science.

Chicago-tyylinen lähdeviittaus

Pao, William, Vincent A. Miller, Katerina A. Politi, Gregory J. Riely, Romel Somwar, Maureen F. Zakowski, Mark G. Kris, ja Harold Varmus. Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated With a Second Mutation in the EGFR Kinase Domain. Public Library of Science, 2005.

MLA-viite

Pao, William, et al. Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated With a Second Mutation in the EGFR Kinase Domain. Public Library of Science, 2005.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.